Azithromycin alters spatial and temporal dynamics of airway microbiota in idiopathic pulmonary fibrosis

Background High bacterial burden in the lung microbiota predicts progression of idiopathic pulmonary fibrosis (IPF). Azithromycin (AZT) is a macrolide antibiotic known to alter the lung microbiota in several chronic pulmonary diseases, and observational studies have shown a positive effect of AZT on...

Full description

Bibliographic Details
Main Authors: Pieter-Jan Gijs, Cécile Daccord, Eric Bernasconi, Martin Brutsche, Christian F. Clarenbach, Katrin Hostettler, Sabina A. Guler, Louis Mercier, Niki Ubags, Manuela Funke-Chambour, Christophe von Garnier
Format: Article
Language:English
Published: European Respiratory Society 2023-05-01
Series:ERJ Open Research
Online Access:http://openres.ersjournals.com/content/9/3/00720-2022.full